Menu
Back to Journals » Neuropsychiatric Disease and Treatment » Volume 18
Original Research
Serum NOX1 and Raftlin as New Potential Biomarkers of Interest in Schizophrenia: A Preliminary Study
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,482 | Dovepress* | 3,320+ | 64 | 3,384 | |
| PubMed Central* | 162 | 138 | 300 | ||
| Totals | 3,482 | 202 | 3,684 | ||
| *Since 2 November 2022 | |||||
View citations on PubMed Central and Google Scholar